← Open Payments lookup

HOLLY SWENSEN: Open Payments

NPI 1386672012 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$674 in 28 payments from 16 companies in 2025. Trend: 2023 $1,154 · 2024 $2,136 · 2025 $674

Food & beverage: $574Education: $100
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$160
ABBVIE INC.3$82
E.R. Squibb & Sons, L.L.C.5$79
Janssen Biotech, Inc.2$42
Incyte Corporation2$39
Bayer Healthcare Pharmaceuticals Inc.1$30
Genmab U.S., Inc.1$30
Celgene Corporation1$30
Rigel Pharmaceuticals, Inc.1$28
SERVIER PHARMACEUTICALS LLC1$28

Products named: LYNPARZA, EPKINLY, OPDIVO, JAKAFI, Nubeqa, Tivdak, REBLOZYL, IMFINZI.

Industry payments across ID — which companies pay providers there.